semaglutide plus bpc 157 BPC-157: The Secret Weapon for Injury Repair & Gut Health | Desert Mobile Medical Think twice before injecting peptides

6.4 Translational challenges and opportunities The peptide systems mediating bonemusclefat crosstalk share several translational challenges

New England Journal of Medicine (SURMOUNT-1)

Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]

Observational Evidence for GLP-1RAs Real-world data in ARDs, particularly rheumatoid arthritis and systemic lupus erythematosus, suggest GLP-1RA use is associated with lower rates of major adverse cardiovascular events and all-cause mortality, mirroring findings in broader populations

Bttner et al., 1988